Mutinda Cleophas Kyama | Medicine and Health Sciences | Research Excellence Award

Published on by Innovation Technologist

Research Excellence Award

Cleophas Mutinda Kyama
Jomo Kenyatta University of Agriculture and Technology, Kenya
Cleophas Mutinda Kyama
Affiliation Jomo Kenyatta University of Agriculture and Technology
Country Kenya
Scopus ID 57216717397
Documents 65
Citations 2,698
h-index 29
Subject Area Medicine and Health Sciences
Event Global Innovation Technologist Awards
ORCID 0000-0001-6459-1514

Cleophas Mutinda Kyama is a Kenyan biomedical scientist, clinical cytologist, and academic researcher associated with the Jomo Kenyatta University of Agriculture and Technology (JKUAT). His scholarly contributions span cancer biology, molecular diagnostics, parasitology, toxicology, infectious disease detection, and translational biomedical sciences. His publication record demonstrates sustained engagement in interdisciplinary health science research with applications in oncology, infectious diseases, immunology, and molecular medicine.[1] The researcher has received significant scholarly attention through citations and collaborative biomedical investigations, particularly in cervical cancer diagnostics, phytomedicine, CRISPR-based diagnostic technologies, and antivenom development.[2]

Abstract

The Research Excellence Award recognition article documents the scholarly achievements and biomedical research contributions of Cleophas Mutinda Kyama. His scientific portfolio encompasses molecular diagnostics, oncology, pharmacological investigations, parasitology, immunological research, and translational health sciences. Through peer-reviewed publications, collaborative international research, and laboratory-based innovations, Kyama has contributed to the advancement of diagnostic technologies and therapeutic investigations relevant to public health challenges in Africa and globally.[3] The researcher’s work demonstrates integration of computational biology, molecular docking, in vitro experimentation, and nanotechnology-assisted diagnostics, reflecting contemporary interdisciplinary scientific approaches.[4]

Keywords

Biomedical Sciences; Molecular Diagnostics; Cervical Cancer Research; CRISPR-Cas12a; Oncology; Cytology; Antivenom Research; Pharmacology; Translational Medicine; Public Health Research; Cancer Therapeutics; Computational Biology.

Introduction

Biomedical and translational health sciences have increasingly relied upon interdisciplinary approaches integrating molecular biology, computational modeling, immunology, and experimental medicine. Within this scientific landscape, Cleophas Mutinda Kyama has contributed to research efforts addressing infectious diseases, cancer diagnostics, toxicology, and therapeutic screening technologies.[5] His work has emphasized practical healthcare applications, particularly within African biomedical contexts where diagnostic accessibility and disease management remain major public health priorities.

Kyama’s research trajectory demonstrates sustained engagement in clinically relevant investigations involving HPV-associated cervical cancer screening, SARS-CoV-2 detection systems, phytochemical anticancer studies, and venom toxicology. Several of his investigations combine computational methodologies with laboratory validation, contributing to evidence-based biomedical innovation and translational healthcare research.[6]

Research Profile

Cleophas Mutinda Kyama served at Jomo Kenyatta University of Agriculture and Technology as a Biomedical Scientist and Senior Lecturer in Medical Laboratory Sciences. His academic and professional work has focused on laboratory diagnostics, cytology, cancer biology, molecular therapeutics, and pathogen detection technologies.[1]

The researcher’s Scopus profile reports 65 scholarly documents with 2,698 citations and an h-index of 29, reflecting measurable scientific visibility and sustained citation impact across biomedical disciplines.[1] His work has appeared in journals including PLOS ONE, BMC Complementary Medicine and Therapies, Diagnostics, Toxicon: X, Toxins, and the South African Journal of Botany.

  • Research specialization in molecular diagnostics and biomedical laboratory sciences.
  • Interdisciplinary research combining computational biology and experimental medicine.
  • Published investigations involving oncology, toxicology, parasitology, and virology.
  • Contributions to public health-oriented biomedical innovation.

Research Contributions

Among Kyama’s notable scientific contributions are investigations into cervical cancer therapeutics and molecular screening technologies. His 2025 study in PLOS ONE explored the molecular mechanisms of Solanecio mannii aqueous root extracts against cervical cancer using computational and experimental validation methodologies.[2]

Additional research explored network pharmacology and molecular docking strategies for prostate cancer treatment investigations using Aspilia pluriseta. These studies integrated in vitro analysis with computational biology techniques to evaluate antiproliferative activity and potential therapeutic mechanisms.[3]

Kyama also contributed to advanced infectious disease diagnostics through CRISPR-Cas12a and hybridization chain reaction methodologies for SARS-CoV-2 detection. This work reflected the growing importance of rapid molecular diagnostic systems during global public health emergencies.[4]

In toxicological and immunological sciences, his studies investigated venom lethality, monoclonal antibody development, and antivenom efficacy involving Naja ashei toxins. These investigations contributed to understanding envenomation management and toxin-neutralizing biomedical strategies.[7]

Publications

Selected publications associated with Cleophas Mutinda Kyama include peer-reviewed journal articles, preprints, and translational biomedical studies relevant to oncology, diagnostics, toxicology, and parasitology.

  1. Computational investigation and experimental validation of the molecular mechanism of Solanecio mannii aqueous roots extract against cervical cancer. PLOS ONE (2025).
  2. Network pharmacology, molecular docking, and in vitro study on Aspilia pluriseta against prostate cancer. BMC Complementary Medicine and Therapies (2024).
  3. Application of Hybridization Chain Reaction/CRISPR-Cas12a for the Detection of SARS-CoV-2 Infection. Diagnostics (2023).
  4. Evaluation of lethality and cytotoxic effects induced by Naja ashei venom and efficacy of selected antivenoms in Kenya. Toxicon: X (2022).
  5. Development and Characterization of Anti-Naja ashei Three-Finger Toxins-Specific Monoclonal Antibodies. Toxins (2022).

Research Impact

The scientific impact of Cleophas Mutinda Kyama’s work is reflected through citation metrics, interdisciplinary collaborations, and practical biomedical applications. His investigations into molecular diagnostics and therapeutic evaluation contribute to contemporary discussions surrounding affordable healthcare technologies, precision diagnostics, and evidence-based medicinal research.[4]

Research involving CRISPR-based diagnostics and nanoparticle-assisted detection systems demonstrates alignment with emerging biomedical technologies that support rapid pathogen identification and translational healthcare innovation.[8] Similarly, his toxicological and antivenom studies address healthcare concerns related to snakebite management in endemic regions.

The integration of phytomedicine, computational molecular analysis, and laboratory validation techniques further reflects a multidisciplinary scientific framework capable of supporting future biomedical innovation and collaborative translational research initiatives.[3]

Award Suitability

The scholarly profile of Cleophas Mutinda Kyama demonstrates characteristics associated with international academic recognition and research excellence awards. His documented publication history, citation impact, interdisciplinary biomedical investigations, and sustained engagement in translational health sciences collectively support recognition within the framework of the Global Innovation Technologist Awards.[1]

  • Demonstrated publication productivity in indexed scientific journals.
  • Strong citation impact and measurable academic influence.
  • Contributions to molecular diagnostics and translational medicine.
  • Interdisciplinary biomedical innovation relevant to public health.
  • Research engagement involving computational and experimental methodologies.

Conclusion

Cleophas Mutinda Kyama has established a research profile characterized by interdisciplinary biomedical inquiry, molecular diagnostic innovation, and translational scientific investigations addressing major health challenges. His academic contributions in oncology, toxicology, molecular biology, and infectious disease diagnostics demonstrate sustained scholarly engagement and measurable scientific impact.[5] Through collaborative biomedical research and publication activity, his work contributes to evolving scientific understanding within medicine and health sciences while supporting broader healthcare research objectives relevant to emerging global health priorities.

References

  1. Elsevier. (n.d.). Scopus author details: Cleophas Mutinda Kyama, Author ID 57216717397. Scopus.
    https://www.scopus.com/authid/detail.uri?authorId=57216717397
  2. Kyama, C. M. et al. (2025). Computational investigation and experimental validation of the molecular mechanism of Solanecio mannii aqueous roots extract against cervical cancer. PLOS ONE.
    https://doi.org/10.1371/journal.pone.0323680
  3. Kyama, C. M. et al. (2024). Network pharmacology, molecular docking, and in vitro study on Aspilia pluriseta against prostate cancer. BMC Complementary Medicine and Therapies.
    https://doi.org/10.1186/s12906-024-04642-8
  4. Kyama, C. M. et al. (2023). Application of Hybridization Chain Reaction/CRISPR-Cas12a for the Detection of SARS-CoV-2 Infection. Diagnostics.
    https://doi.org/10.3390/diagnostics13091644
  5. Jomo Kenyatta University of Agriculture and Technology. (n.d.). Medical Laboratory Sciences and Biomedical Research Activities.
  6. Kyama, C. M. et al. (2022). Expression of the Fab enzymes from Plasmodium falciparum after exposure to Artemisia afra plant extracts. Journal of Parasitic Diseases.
    https://doi.org/10.1007/s12639-022-01537-8
  7. Kyama, C. M. et al. (2022). Development and Characterization of Anti-Naja ashei Three-Finger Toxins-Specific Monoclonal Antibodies. Toxins.
    https://doi.org/10.3390/toxins14040285
  8. Kyama, C. M. et al. (2020). Development of HPV 16/18 E6 oncoprotein paper-based nanokit for enhanced cervical cancer screening.
    https://doi.org/10.1101/2020.04.29.20084459

Aqsa Zafar | Agricultural and Biological Sciences | Young Researcher Award

Published on by Innovation Technologist

Young Researcher Award

Aqsa Zafar
Kohsar University Murree, Pakistan
Aqsa Zafar
Affiliation Kohsar University Murree
Country Pakistan
Scopus ID 59511873400
Documents 4
Citations 2
h-index 1
Subject Area Agricultural and Biological Sciences
Event Global Innovation Technologist Awards
ORCID 0009-0007-5802-1655

The Young Researcher Award recognizes emerging scholars demonstrating promising contributions in interdisciplinary biosciences, environmental sciences, and applied biological research. Aqsa Zafar, affiliated with Kohsar University Murree and formerly associated with Capital University of Science and Technology, Islamabad, has contributed to scientific investigations involving nanotechnology, computational biosciences, plant biotechnology, and environmental applications.[1] Her research profile reflects active engagement in academic development, scientific publication, and interdisciplinary collaboration within Pakistan’s higher education and research ecosystem.[2]

Abstract

Aqsa Zafar is a Pakistani researcher whose academic activities encompass biosciences, environmental sciences, nanotechnology, and computational biology. Her scholarly work includes investigations into green synthesized nanoparticles, bio-fertilizer applications, and computational therapeutic analyses involving medicinal plant compounds.[3] Her research demonstrates a multidisciplinary orientation combining experimental biology, environmental sustainability, and bioinformatics methodologies. Through publications indexed in recognized academic platforms and participation in institutional research initiatives, she has established an emerging profile suitable for early-career academic recognition.[4]

Keywords

  • Young Researcher Award
  • Biosciences
  • Environmental Sciences
  • Nanotechnology
  • Computational Biology
  • Agricultural and Biological Sciences

Introduction

Contemporary biological sciences increasingly emphasize interdisciplinary integration involving computational methods, environmental sustainability, and applied biotechnology. Emerging researchers contributing to these domains frequently engage with experimental and analytical approaches designed to address ecological, agricultural, and biomedical challenges.[5]

Aqsa Zafar’s academic background includes graduate-level biosciences education from Capital University of Science and Technology, Islamabad, together with earlier qualifications in zoology from the Islamia University of Bahawalpur. Her professional and academic engagements include teaching, research training, laboratory internships, and institutional collaboration within Pakistani academic institutions.[2] These experiences have supported her development as an early-career researcher working at the intersection of environmental biology and applied biosciences.

Research Profile

The research profile of Aqsa Zafar includes publications indexed in Scopus alongside academic activities associated with biosciences and environmental studies. According to available author metrics, her scholarly profile includes four indexed documents, two citations, and an h-index of 1.[1]

Her academic appointments include service as a Visiting Lecturer in the Department of Environmental Sciences at Kohsar University Murree, as well as prior academic and teaching engagements in Islamabad and Rawalpindi. Her educational background reflects progression from zoological sciences toward computational and interdisciplinary bioscience research.[2]

  • MS in Biosciences from Capital University of Science and Technology
  • Master of Science in Zoology from Islamia University of Bahawalpur
  • Research involvement in nanotechnology and bioinformatics
  • Teaching and environmental science academic activities

Research Contributions

Aqsa Zafar has contributed to research associated with environmentally sustainable synthesis methods and biological applications of nanomaterials. One of her studies investigated the in vivo toxicological evaluation of green synthesized silica nanoparticles using Ficus carica leaf extract in Sprague Dawley rats, reflecting an interest in biosafe nanotechnology applications and toxicological assessment methodologies.[6]

Her research also includes investigations into agricultural biotechnology, particularly the role of Chlorella vulgaris as a potential bio-fertilizer for Lycopersicon esculentum. This work contributes to ongoing discussions concerning sustainable agricultural enhancement and eco-friendly crop productivity approaches.[7]

Another publication explored the therapeutic potential of Asparagus africanus in polycystic ovarian syndrome using computational analysis. The study incorporated bioinformatics-oriented approaches to evaluate potential therapeutic interactions and demonstrates engagement with computational bioscience methodologies.[8]

Publications

  1. “In vivo toxicological evaluation of green synthesized silica nanoparticles from Ficus carica leaf extract in Sprague Dawley rats,” Inorganic Chemistry Communications, 2025.
  2. “Effect of Chlorella vulgaris as a Potential Bio-fertilizer on Lycopersicon esculentum,” Plant Bulletin, 2025.
  3. “Exploring the therapeutic potential of Asparagus africanus in polycystic ovarian syndrome: a computational analysis,” Journal of Integrative Bioinformatics, 2025.

Research Impact

The emerging research impact of Aqsa Zafar is reflected through indexed publications, citation activity, and interdisciplinary thematic focus. Her work contributes to areas including environmental biotechnology, nanotoxicology, sustainable agriculture, and computational therapeutic research.[6]

The integration of green synthesis methodologies with toxicological and agricultural applications aligns with broader global research priorities emphasizing sustainability, environmental compatibility, and applied biological innovation. Her publications further indicate participation in contemporary bioscience discourse involving data-driven and computational biological analysis.[7]

Award Suitability

The Young Researcher Award category is generally intended to acknowledge early-career scholars demonstrating measurable academic promise, interdisciplinary engagement, and research productivity. Aqsa Zafar’s scholarly activities indicate alignment with these criteria through her contributions to biosciences, environmental studies, and computational biological research.[1]

Her combination of teaching, research, and interdisciplinary publication activity demonstrates professional engagement within emerging scientific fields. Participation in indexed journal publications and scientific investigations involving sustainable technologies and biomedical analysis further supports the relevance of her profile for recognition within the Global Innovation Technologist Awards framework.[4]

Conclusion

Aqsa Zafar represents an emerging academic researcher contributing to interdisciplinary biosciences and environmental research domains. Her work encompasses green nanotechnology, agricultural biotechnology, and computational therapeutic analysis supported by institutional research and teaching experience. Through indexed scholarly publications and academic engagement, she demonstrates the characteristics commonly associated with developing scientific leadership and early-career research distinction.[3]

References

  1. Elsevier. (n.d.). Scopus author details: Aqsa Zafar, Author ID 59511873400. Scopus.
    www.scopus.com/authid/detail.uri?authorId=59511873400
  2. ORCID. (n.d.). Aqsa Zafar professional and academic profile. ORCID Registry.
    orcid.org/0009-0007-5802-1655
  3. Journal of Integrative Bioinformatics. (2025). Exploring the therapeutic potential of Asparagus africanus in polycystic ovarian syndrome: a computational analysis.
    https://doi.org/10.1515/jib-2024-0019
  4. Global Innovation Technologist Awards. (n.d.). Award recognition platform for emerging scientific and technological contributions.
    innovationtechnologist.com
  5. Capital University of Science and Technology. (n.d.). Department of Bioinformatics and Biosciences academic information.
  6. Inorganic Chemistry Communications. (2025). In vivo toxicological evaluation of green synthesized silica nanoparticles from Ficus carica leaf extract in Sprague Dawley rats.
  7. Plant Bulletin. (2025). Effect of Chlorella vulgaris as a Potential Bio-fertilizer on Lycopersicon esculentum. https://doi.org/10.55627/pbulletin.004.01.835
  8. Journal of Integrative Bioinformatics. (2025). Computational analysis involving Asparagus africanus and polycystic ovarian syndrome therapeutic potential.

Supriyo Chakraborty | Biotechnology | Research Excellence Award

Published on by Innovation Technologist

Dr. Supriyo Chakraborty | Biotechnology | Research Excellence Award

Professor at Assam University | India

Dr. Supriyo Chakraborty is a distinguished biotechnology researcher and academic leader whose work spans plant genetics, molecular biology, bioinformatics, and population genetics. Renowned for his impactful contributions, he has authored a substantial body of research, reflected in 4911 citations (3972 since 2020), an h-index of 29 (24 since 2020), and an i10-index of 80 (54 since 2020). His research advances codon usage bias analysis, gene expression prediction, RNA virus genomics, and computational tools for genetic and peptide property analysis. He has developed multiple awarded software innovations that enhance genomic interpretation and statistical genetics, widely used across plant, animal, and microbial systems. His notable work includes microRNA-based viral gene silencing models, codon usage and RNA editing studies in bat-borne viruses, and gene regulation mechanisms in neurobiological conditions. His contributions to QTL mapping in rice, maize, and Drosophila have supported crop improvement and advanced quantitative genetics. He has also generated important insights into human population genetics through studies on ABO and Rh gene frequencies and genetic distance estimation. As a professor of biotechnology, he has mentored numerous doctoral scholars and strengthened research and teaching in genetics, molecular biology, and plant biotechnology. His scholarly books, book chapters, popular articles, and extensive participation in national and international scientific programs reflect his commitment to advancing scientific knowledge. Dr. Chakraborty’s multifaceted research portfolio and lasting contributions place him among the leading figures in contemporary biotechnology and genetic research.

Profile: Google Scholar

Featured Publications

Malakar, A. K., Choudhury, D., Halder, B., Paul, P., Uddin, A., & Chakraborty, S. (2019). A review on coronary artery disease, its risk factors, and therapeutics. Journal of Cellular Physiology, 234(10), 16812–16823.

Paul, P., Chakraborty, A., Sarkar, D., Langthasa, M., Rahman, M., Bari, M., & Chakraborty, S. (2018). Interplay between miRNAs and human diseases. Journal of Cellular Physiology, 233(3), 2007–2018.

Khawbung, J. L., Nath, D., & Chakraborty, S. (2021). Drug resistant Tuberculosis: A review. Comparative Immunology, Microbiology and Infectious Diseases, 74, 101574.

Deb, B., Uddin, A., & Chakraborty, S. (2018). miRNAs and ovarian cancer: An overview. Journal of Cellular Physiology, 233(5), 3846–3854.

Barman, A., Deb, B., & Chakraborty, S. (2020). A glance at genome editing with CRISPR Cas9 technology. Current Genetics, 66, 447–462.